Εμφάνιση απλής εγγραφής

dc.creatorDafopoulos K.en
dc.date.accessioned2023-01-31T07:48:53Z
dc.date.available2023-01-31T07:48:53Z
dc.date.issued2019
dc.identifier10.1201/9781315165707-19
dc.identifier.isbn9781351677912; 9781138055780
dc.identifier.urihttp://hdl.handle.net/11615/72992
dc.description.abstractCouples with RIF need counseling regarding when they should abandon IVF cycles and be offered alternative treatment options such as gamete donation or surrogacy. Although there are no epidemiological data on cumulative success rates following various treatments in RIF patients, a rational approach based on current literature is presented. Patients below 40 years of age, after correction of the RIF-related condition may extend the number of subsequent cycles up to nine. Patients aged 40–42 years may benefit from six further cycles, which should be performed in a short period, avoiding a significant delay that has aging-related negative effects on both pregnancy rates and pregnancy outcome. Patients older than 42 years have very low live-birth rates per cycle and should be counseled that less than five cycles should be further offered without delaying entering an oocyte-donation program. © 2020 by Taylor & Francis Group, LLC.en
dc.language.isoenen
dc.sourceRecurrent Implantation Failureen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85141045302&doi=10.1201%2f9781315165707-19&partnerID=40&md5=31ed1bd5a38739fd183cb11d62fbe6a1
dc.subjectCRC Pressen
dc.titleWhen should patients abandon treatment?en
dc.typebookChapteren


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής